Dishman Pharmaceuticals & Chemicals Ltd has informed BSE that the Board of Directors of the Company on March 17, 2008, has allotted 10,13,023 equity shares of Rs 2/- each of the Company at a premium of Rs 170/- per equity share upon exercise of option for conversion of 0.50% Foreign Currency Convertible Bonds (FCCB) of the principal amount of US$ 4,000,000, into the equity shares of the Company, by a bondholder.

Consequently, the paid-up equity share capital of the Company has increased from 78671090 equity shares of Rs 2/- each to 79684113 equity shares of Rs 2/- each.